UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 8, 2006
PROXYMED, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Florida
|
|
000-22052
|
|
65-0202059 |
| (State or other jurisdiction of
|
|
(Commission File No.)
|
|
(IRS Employer |
| incorporation)
|
|
|
|
Identification No.) |
1854 Shackleford Court, Suite 200,
Norcross, Georgia 30093-2924
(Address of principal executive offices)
(770) 806-9918
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On August 8, 2006, ProxyMed, Inc. d/b/a MedAvant Healthcare Solutions ( “MedAvant”) announced its
financial results for its second quarter ended June 30, 2006. The full text of the press release
issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on
Form 8-K. Additionally, on August 9, 2006, MedAvant will hold a teleconference call to report
its financial and operating results for the quarter ended June 30, 2006.
FORWARD LOOKING STATEMENTS — Statements in this release that are “forward-looking statements” are
based on current expectations and assumptions that are subject to risks and uncertainties. In some
cases, forward-looking statements can be identified by terminology such as “may,” “should,”
“potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and
similar expressions. Actual results could differ materially from projected results because of
factors such as: the soundness of MedAvant’s business strategies relative to the perceived market
opportunities; MedAvant’s ability to successfully develop, market, sell, cross-sell, install and
upgrade its clinical and financial transaction services and applications to current and new
physicians, payers, medical laboratories and pharmacies; the ability to compete effectively on
price and support services; MedAvant’s ability and that of its business associates to perform
satisfactorily under the terms of its contractual obligations, and to comply with various
government rules regarding healthcare and patient privacy; entry into markets with vigorous
competition, market acceptance of existing products and services, changes in licensing programs,
product price discounts, delays in product development and related product release schedules, any
of which may cause revenues and income to fall short of anticipated levels; the availability of
competitive products or services; the continued ability to protect our intellectual property
rights, implementation of operating cost structures that align with revenue growth; uninsured
losses; adverse results in legal disputes resulting in liabilities; unanticipated tax liabilities;
the effects of a natural disaster or other catastrophic event beyond our control that results in
the destruction or disruption of any of our critical business or information technology systems.
Any of these factors could cause the actual results to differ materially from the guidance given at
this time. MedAvant refers you to the cautionary statements and risk factors set forth in the
documents MedAvant files from time to time with the Securities and Exchange Commission,
particularly MedAvant’s form 10K/A for the year ended December 31, 2005.
MedAvant does not assume any obligation to update information contained in this document. Although
the release attached hereto as Exhibit 99.1 may remain available on MedAvant’s website or
elsewhere, its continued availability does not indicate that MedAvant is reaffirming or confirming
any of the information contained therein.
Item 9.01 Financial Statements and Exhibit.
(d) Exhibits
| |
|
|
| Exhibit No. |
|
Description |
99.1
|
|
Press release of MedAvant dated August 8, 2006, reporting
financial results for the second quarter ended June 30, 2006. |